Xontogeny Revenue and Competitors
Estimated Revenue & Valuation
- Xontogeny's estimated annual revenue is currently $2.6M per year.
- Xontogeny's estimated revenue per employee is $155,000
Employee Data
- Xontogeny has 17 Employees.
- Xontogeny grew their employee count by 0% last year.
Xontogeny's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Legal | Reveal Email/Phone |
2 | Director Administration | Reveal Email/Phone |
3 | Senior Director, Strategic and Financial Planning | Reveal Email/Phone |
4 | Senior Manager, Program Development | Reveal Email/Phone |
5 | Partner | Reveal Email/Phone |
6 | Advisor/Consultant, Clinical Operations | Reveal Email/Phone |
7 | Principal | Reveal Email/Phone |
8 | Partner, R&D | Reveal Email/Phone |
9 | Senior Associate | Reveal Email/Phone |
10 | Associate | Reveal Email/Phone |
Xontogeny Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $3470M | 2330 | -17% | $862K | $49.2B |
What Is Xontogeny?
Xontogeny (zon-TOJ-uh-nee) is a biotech aggregator with a differentiated business model to support the accelerated development of life science technologies in the pursuit of helping patients with serious diseases. Speciï¬cally, we partner with entrepreneurs, providing the leadership and operating experience needed to increase the probability of success with early drug and technology development. At Xontogeny, we believe that scientific founders supply the passion and determination integral to the success of their companies. While the foundation of success is good science, how that science is developed from inception to maturity serves as the critical pathway. Therefore, we focus on supporting the entrepreneur's pursuit and optimizing the development pathway with an exceptionally talented and experienced operational team. With our team's track record of success, entrepreneurs of affiliated companies will gain the support and guidance they need while remaining lean, virtual, and without the financial burden of supporting a full-time team. This dynamic model has the additional benefit of supporting the goals of the founding scientists and entrepreneurs to retain more control and equity, while increasing the chance of accessing investment, and ultimately development success.
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Xontogeny News
PXV Fund enables Perceptive to make early-stage investments in life science startups, including those seeded and incubated at Garabedian's Xontogeny...
We are thrilled to welcome a collaboration with the team at Xontogeny as we work to advance our lead compound through IND-enabling studies.
Funding round co-led by the Perceptive Xontogeny Venture (PXV) Fund and Switzerland-based Debiopharm Innovation Fund. NEWPORT BEACH, Calif.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.3M | 17 | -53% | N/A |
#2 | $1.5M | 17 | -6% | N/A |
#3 | $1.5M | 17 | -11% | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |